发明名称 |
Alvac canarypox virus recombinants comprising heterlogous inserts |
摘要 |
What is described is a modified vector, such as a recombinant poxvirus, particularly recombinant vaccinia virus, having enhanced safety. The modified recombinant virus has nonessential virus-encoded genetic functions inactivated therein so that virus has attenuated virulence. In one embodiment, the genetic functions are inactivated by deleting an open reading frame encoding a virulence factor. In another embodiment, the genetic functions are inactivated by insertional inactivation of an open reading frame encoding a virulence factor. What is also described is a vaccine containing the modified recombinant virus having nonessential virus-encoded genetic functions inactivated therein so that the vaccine has an increased level of safety compared to known recombinant virus vaccines./!
|
申请公布号 |
US5756103(A) |
申请公布日期 |
1998.05.26 |
申请号 |
US19950457007 |
申请日期 |
1995.06.01 |
申请人 |
VIROGENETICS CORPORATION |
发明人 |
PAOLETTI, ENZO;PERKUS, MARION E.;TAYLOR, JILL;TARTAGLIA, JAMES;NORTON, ELIZABETH K.;RIVIERE, MICHEL;DE TAISNE, CHARLES;LIMBACH, KEITH J.;JOHNSON, GERARD P.;PINCUS, STEVEN E.;COX, WILLIAM I.;AUDONNET, JEAN-CHRISTOPHE FRANCIS;GETTIG, RUSSELL ROBERT |
分类号 |
A61K39/12;A61K39/00;A61K39/08;A61K39/15;A61K39/165;A61K39/17;A61K39/175;A61K39/205;A61K39/21;A61K39/23;A61K39/245;A61K39/275;A61K39/285;A61K39/29;A61P31/04;A61P31/12;A61P31/14;A61P31/16;A61P31/18;A61P31/20;A61P31/22;C07H21/04;C07K1/00;C07K14/015;C07K14/02;C07K14/03;C07K14/035;C07K14/045;C07K14/05;C07K14/06;C07K14/065;C07K14/07;C07K14/11;C07K14/12;C07K14/125;C07K14/145;C07K14/15;C07K14/155;C07K14/16;C07K14/175;C07K14/18;C07K14/33;C12N7/00;C12N7/01;C12N7/04;C12N7/08;C12N15/00;C12N15/09;C12N15/86;C12N15/863;C12P21/06;C12R1/93;(IPC1-7):A61K39/12 |
主分类号 |
A61K39/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|